Drug Shortage Report for MULTI-12/K1 PEDIATRIC
| Report ID | 215358 |
| Drug Identification Number | 02242529 |
| Brand name | MULTI-12/K1 PEDIATRIC |
| Common or Proper name | MULTI-12/K1 PED |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | VITAMIN B12 FOLIC ACID BIOTIN VITAMIN K1 VITAMIN E DEXPANTHENOL NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID |
| Strength(s) | 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG 400UNIT 2300UNIT 80MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | SINGLE DOSE 10LIVI |
| ATC code | B05XC |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-08 |
| Estimated end date | 2024-01-26 |
| Actual end date | 2024-02-05 |
| Shortage status | Resolved |
| Updated date | 2024-02-06 |
| Company comments | Baxter item: 6461. Product is available on allocation based on 100% of historical volumes |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-02-06 | English | Compare |
| v6 | 2024-02-05 | French | Compare |
| v5 | 2024-02-05 | English | Compare |
| v4 | 2024-01-09 | English | Compare |
| v3 | 2024-01-08 | French | Compare |
| v2 | 2024-01-08 | English | Compare |
| v1 | 2024-01-08 | English | Compare |
Showing 1 to 7 of 7